These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22507865)

  • 1. Management of complaints in blood establishments: thirteen years of experience at the Croatian Institute of Transfusion Medicine.
    Vuk T; Barišić M; Očić T; Đogić V; Bingulac-Popović J; Sarlija D; Balija M; Jukić I
    Blood Transfus; 2012 Jul; 10(3):302-10. PubMed ID: 22507865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Error management in blood establishments: results of eight years of experience (2003-2010) at the Croatian Institute of Transfusion Medicine.
    Vuk T; Barišić M; Očić T; Mihaljević I; Sarlija D; Jukić I
    Blood Transfus; 2012 Jul; 10(3):311-20. PubMed ID: 22395352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Product recall: a Croatian experience (2000-2010).
    Vuk T; Barišić M; Ljubičić J; Hećimović A; Juraković-Lončar N; Šarlija D; Jukić I
    Blood Transfus; 2013 Jul; 11(3):433-40. PubMed ID: 23114522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial contamination of blood products at the Croatian Institute of Transfusion Medicine: results of eleven-year monitoring.
    Vuk T; Barišić M; Hećimović A; Rukavina L; Batarilo I; Šarlija D; Jukić I
    Transfus Med; 2012 Dec; 22(6):432-9. PubMed ID: 23020303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safe handling and administration of blood components: review of practical concepts.
    Osby MA; Saxena S; Nelson J; Shulman I
    Arch Pathol Lab Med; 2007 May; 131(5):690-4. PubMed ID: 17488153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of errors in blood component transfusion records with regard to quality improvement of data acquisition and to the performance of lookback and traceback procedures.
    Zimmermann R; Linhardt C; Weisbach V; Büscher M; Zingsem J; Eckstein R
    Transfusion; 1999 Apr; 39(4):351-6. PubMed ID: 10220259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
    Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Are the indications and choice of labile blood products adapted? National survey on prescriber's knowledge].
    Rieux C; Bastuji-Garin S; Vicariot M; Chenais F; Courtois F; Waller C; Quaranta JF; Bierling P;
    Presse Med; 2003 Sep; 32(29):1352-8. PubMed ID: 14534496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical aspects of the self-assessment of the issue and administration of blood: a review of two hospitals' experiences.
    Shulman IA; Jones FS
    Am J Clin Pathol; 1997 Apr; 107(4 Suppl 1):S17-22. PubMed ID: 9124224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A computer-assisted transfusion management system and changed transfusion practices contribute to appropriate management of blood components.
    Ohsaka A; Abe K; Ohsawa T; Miyake N; Sugita S; Tojima I
    Transfusion; 2008 Aug; 48(8):1730-8. PubMed ID: 18482189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing.
    Heddle NM; O'Hoski P; Singer J; McBride JA; Ali MA; Kelton JG
    Br J Haematol; 1992 Aug; 81(4):579-84. PubMed ID: 1390245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How we treat: transfusion medicine support of obstetric services.
    Goodnough LT; Daniels K; Wong AE; Viele M; Fontaine MF; Butwick AJ
    Transfusion; 2011 Dec; 51(12):2540-8. PubMed ID: 21542850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The legally required guidelines for reporting risks or side-effects caused by blood components].
    Radtke H; Bachmann K; Pindur G; Koscielny J; Wenzel E; Kiesewetter H
    Infusionsther Transfusionsmed; 1995 Jun; 22(3):186-95. PubMed ID: 7640512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk management from the perspective of the hematologist].
    Gossrau E
    Z Arztl Fortbild Qualitatssich; 2003 Nov; 97(8-9):618-21. PubMed ID: 14710657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Croatian pharmaceutical sector reform project: rational drug use.
    Harvey K; Kalanj K; Stevanović R
    Croat Med J; 2004 Oct; 45(5):611-9. PubMed ID: 15495290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of blood component use in cirrhosis: a nationwide study.
    Desborough MJ; Hockley B; Sekhar M; Burroughs AK; Stanworth SJ; Jairath V;
    Liver Int; 2016 Apr; 36(4):522-9. PubMed ID: 26537012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quality assurance management system for therapy with blood and blood products].
    Diekamp U
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Oct; 33(10):664-5. PubMed ID: 9825053
    [No Abstract]   [Full Text] [Related]  

  • 19. [Quality indicators and dashboards: the experience of a collection department].
    Danic B; Bécel C; Beauplet A
    Transfus Clin Biol; 2000 Apr; 7(2):189-97. PubMed ID: 10812662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriateness of blood product transfusion in the Obstetrics and Gynaecology (O&G) department of a tertiary hospital in West Africa.
    Osei EN; Odoi AT; Owusu-Ofori S; Allain JP
    Transfus Med; 2013 Jun; 23(3):160-6. PubMed ID: 23672710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.